Hong Kong Mortgage Finance Stock News

The latest development at Alphamab Oncology (SEHK:9966) involves China’s regulator formally accepting its new drug application for KN035, in combination with Gemcitabine and Oxaliplatin, for first-line treatment of unresectable or metastatic biliary tract cancer. See our latest analysis for Alphamab Oncology. After the NMPA accepted the KN035 filing, Alphamab Oncology’s HK$10.28 share price sits alongside a 1-year total shareholder return of 216.31%, while the 90-day share price return of a...

Inspur Digital Enterprise Technology Limited ( HKG:596 ), is not the largest company out there, but it saw a...

Key Insights Significant insider control over Bloks Group implies vested interests in company growth The top 2...

Kwan Yong Holdings (HKG:9998) has had a great run on the share market with its stock up by a significant 17% over the...

With a median price-to-sales (or "P/S") ratio of close to 0.5x in the Electronic industry in Hong Kong, you could be...

Key Insights Significant control over Scholar Education Group by individual investors implies that the general public...

With a price-to-earnings (or "P/E") ratio of 14.9x Jiangsu Innovative Ecological New Materials Limited ( HKG:2116 ) may...

Key Insights Using the 2 Stage Free Cash Flow to Equity, A & S Group (Holdings) fair value estimate is HK$0.11 A & S...

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Typically, we'll want to notice a...

These days it's easy to simply buy an index fund, and your returns should (roughly) match the market. But if you pick...

You may think that with a price-to-sales (or "P/S") ratio of 0.2x Golden Power Group Holdings Limited ( HKG:3919 ) is a...

When close to half the companies in the Entertainment industry in Hong Kong have price-to-sales ratios (or "P/S") below...

Key Insights ZhongAn Online P & C Insurance's significant retail investors ownership suggests that the key decisions...

The last three months have been tough on Unity Group Holdings International Limited ( HKG:1539 ) shareholders, who have...

Recent performance snapshot With no single headline event driving attention today, Semiconductor Manufacturing International (SEHK:981) has still drawn investor interest after a one-month return of 21.9% and a three-month return of 11.9%. See our latest analysis for Semiconductor Manufacturing International. Viewed over a longer stretch, the recent 21.9% one month share price return builds on a 1 year total shareholder return of 114.9%. This suggests momentum has been strengthening even with...

The COSCO SHIPPING Energy Transportation Co., Ltd. ( HKG:1138 ) share price has done very well over the last month...

As Asian markets continue to navigate a complex global landscape, they are witnessing notable activity across various sectors. Amidst this backdrop, penny stocks—often representing smaller or emerging companies—remain a niche yet intriguing segment for investors seeking potential growth opportunities. While the term 'penny stocks' may seem outdated, these investments can still offer significant value when backed by strong financial health and promising business models.

Johnson Electric Holdings Limited ( HKG:179 ), is not the largest company out there, but it saw significant share price...

Why AbbVie’s RC148 licensing deal matters for RemeGen RemeGen (SEHK:9995) moved into focus after AbbVie signed an exclusive licensing agreement for RC148, a PD-1/VEGF bispecific antibody. The deal grants AbbVie rights outside Greater China and secures sizeable upfront, milestone and royalty economics for RemeGen. See our latest analysis for RemeGen. RemeGen’s share price has responded sharply to the AbbVie announcement, with a 23.53% 1 month share price return and a very large 1 year total...

Sunac China Holdings (SEHK:1918) has drawn fresh attention after reporting unaudited contracted sales for December 2025 and the full year, giving investors a clearer view of recent project activity and buyer demand. See our latest analysis for Sunac China Holdings. The latest unaudited contracted sales update lands after a mixed trading stretch, with a 1 day share price return of 3.45% and a 7 day gain of 1.69%. This is set against a 90 day share price return showing a 21.05% decline and a 1...

Weichai Power (SEHK:2338) is drawing fresh attention after a cluster of governance moves, including the retirement of long serving executive director Sun Shaojun and a detailed reshuffle of board and committee roles. See our latest analysis for Weichai Power. The governance reset comes on the back of strong price momentum, with a 90 day share price return of 49.8% and a 1 year total shareholder return of 76.8%, suggesting sentiment has been improving rather than fading. If this kind of...

In early January 2026, Lenovo unveiled a broad slate of Hybrid AI launches at Tech World @ CES, spanning AI PCs, enterprise AI infrastructure, personal AI agents across devices, and concept form factors, alongside new Chromebooks for education and AI-powered retail solutions. Together with deepened collaborations such as the Lenovo AI Cloud Gigafactory with NVIDIA and new ThinkSystem/ThinkEdge inferencing servers, these announcements underscore Lenovo’s push to embed AI across its device,...

In recent days, Tencent reiterated its commitment to a consistent AI strategy aimed at building higher-quality growth engines across its user, content, infrastructure and monetisation ecosystems, with its 4Q25 topline expected to align with analyst consensus and be supported by AI-enhanced online gaming and advertising. An interesting aspect is that Tencent is willing to absorb higher AI-related operating expenses today in order to expand AI-driven revenue streams across its broader platform...

As global markets continue to navigate a complex landscape, U.S. stocks have shown resilience by rallying at the start of the year, with small-cap and value shares leading the charge. In this context, penny stocks—often overlooked yet still significant—represent an intriguing investment area for those seeking growth opportunities in smaller or newer companies. Despite being considered a niche market, these stocks can offer substantial returns when backed by robust financial health. Let's...